Search results for “Primary Lateral Sclerosis” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 68 patents, we discovered top 18 key players by total patent application. Genzyme Corp., Eli Lilly & Co., MedImmune Ltd. are dominant in this area. They take 60.29% of the total patent filing.
Genzyme Corp.
Massachusetts, United States
Patent: 19
Eli Lilly & Co.
Indiana, United States
Patent: 11
MedImmune Ltd.
Cambridgeshire, United Kingdom
Patent: 11
Hebei Yiling Pharmaceutical Research Institute Co., Ltd.
Hebei Sheng, China
Patent: 4
Takeda Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 3
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 3
Pharnext SA
France
Patent: 3
MediciNova, Inc.
California, United States
Patent: 2
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Hebei Sheng, China
Patent: 1
Merz Pharma GmbH & Co. KGaA
Sachsen, Germany
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 35 patents applied in the last 5 years. We discover 8 most active companies in this area. The fast-growing Eli Lilly & Co., MedImmune Ltd., Regeneron Pharmaceuticals, Inc. take 74.29% of patent filing during this period.
Eli Lilly & Co.
Indiana, United States
Patent: 12
MedImmune Ltd.
Cambridgeshire, United Kingdom
Patent: 11
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 3
Takeda Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 3
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 1
Genzyme Corp.
Massachusetts, United States
Patent: 1
Ningbo Huxin Pharmaceutical Technology Co., Ltd.
Zhejiang Sheng, China
Patent: 1
Institute of Laboratory Animal Science
ZURICH, Switzerland
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 35 patents in last 5 years, we discover 7 new entrants. Eli Lilly & Co., MedImmune Ltd., Regeneron Pharmaceuticals, Inc. are the most active new entrants in this area.
Eli Lilly & Co.
Indiana, United States
Patent: 12
MedImmune Ltd.
Cambridgeshire, United Kingdom
Patent: 11
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 3
Takeda Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 3
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 1
Ningbo Huxin Pharmaceutical Technology Co., Ltd.
Zhejiang Sheng, China
Patent: 1
Institute of Laboratory Animal Science
ZURICH, Switzerland
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 18 patents, we discovered top 4 universities and scientific research institutions by total patent application. Chinese Academy of Medical Scciences & Peking Union Medical College, The Johns Hopkins University, The University of Sheffield are dominant in this area. They take 38.89% of the total patent filing.
Chinese Academy of Medical Scciences & Peking Union Medical College
China
Patent: 3
The Johns Hopkins University
United States
Patent: 1
The University of Sheffield
SHEFFIELD, United Kingdom
Patent: 1
Royal College of Surgeons
Ireland
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: